First Turn Management, LLC
First Turn Management, LLC reported 38 holdings worth US$753M as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
First Turn Management, LLC reported 38 holdings worth US$753M as of Sep 30, 2026. Largest: Enliven Therapeutics, Inc., Guardant Health, Inc. and Abivax SA. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 38
- Value as reported
- US$753M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Enliven Therapeutics, Inc. | 959K | US$43.9M | 5.8% |
| Guardant Health, Inc. | 219K | US$39.1M | 5.2% |
| Abivax SA | 385K | US$38.1M | 5.1% |
| Roivant Sciences Ltd. | 986K | US$36M | 4.8% |
| United Therapeutics Corporation | 60,064 | US$32.5M | 4.3% |
| Viridian Therapeutics, Inc. | 1.53M | US$31.4M | 4.2% |
| Axsome Therapeutics, Inc. | 162K | US$29.9M | 4.0% |
| Insmed Incorporated | 246K | US$28M | 3.7% |
| Celcuity Inc. | 329K | US$26.2M | 3.5% |
| Charles River Laboratories International, Inc. | 86,801 | US$25.6M | 3.4% |
| Cytokinetics, Incorporated | 358K | US$23.6M | 3.1% |
| BridgeBio Pharma, Inc. | 354K | US$23.3M | 3.1% |
| Praxis Precision Medicines, Inc. | 78,806 | US$23M | 3.0% |
| ORIC Pharmaceuticals, Inc. | 1.57M | US$21.2M | 2.8% |
| Repligen Corporation | 108K | US$20.8M | 2.8% |
| Tango Therapeutics, Inc. | 767K | US$19.1M | 2.5% |
| Revolution Medicines, Inc. | 92,316 | US$18.9M | 2.5% |
| Inhibrx Biosciences, Inc. | 172K | US$17.2M | 2.3% |
| Veradermics, Incorporated | 137K | US$16.6M | 2.2% |
| Cogent Biosciences, Inc. | 515K | US$16.5M | 2.2% |
| Dianthus Therapeutics, Inc. | 179K | US$15.7M | 2.1% |
| Palvella Therapeutics, Inc. | 110K | US$15.2M | 2.0% |
| Rhythm Pharmaceuticals, Inc. | 158K | US$15M | 2.0% |
| Arcus Biosciences, Inc. | 578K | US$14.9M | 2.0% |
| Arrowhead Pharmaceuticals, Inc. | 223K | US$14.6M | 1.9% |
| Disc Medicine, Inc. | 221K | US$14.4M | 1.9% |
| Erasca, Inc. | 913K | US$13.4M | 1.8% |
| GRAIL, Inc. | 93,727 | US$13.1M | 1.7% |
| Kymera Therapeutics, Inc. | 113K | US$12.7M | 1.7% |
| Xenon Pharmaceuticals Inc. | 297K | US$11M | 1.5% |
| Spyre Therapeutics, Inc. | 103K | US$9.13M | 1.2% |
| Summit Therapeutics Inc. | 502K | US$8.48M | 1.1% |
| Definium Therapeutics, Inc. | 217K | US$8.24M | 1.1% |
| Vaxcyte, Inc. | 138K | US$7.83M | 1.0% |
| Hinge Health, Inc. | 75,448 | US$7.34M | 0.97% |
| Oruka Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Scholar Rock Holding Corporation | 0 | US$0 | 0.00% |
| Sionna Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Apogee Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Mirum Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Nuvalent, Inc. | 0 | US$0 | 0.00% |
Source
Download original · View original at SEC
Related